Form 4: Orthofix Medical Inc. CFO Julie Andrews Reports Acquisition of Stock Options and Restricted Stock Units

CFO Julie Andrews reports acquisition of stock options and restricted stock units in Orthofix Medical Inc.

Summary

• On March 3, 2025, Julie Andrews, CFO of Orthofix Medical Inc., reported the acquisition of 34,600 shares of common stock and 82,070 employee stock options.
• The common stock was acquired at a price of $0.
• Following the reported transaction, Andrews beneficially owns 62,912 shares of common stock.
• The employee stock options have an exercise price of $16.98 and expire on March 3, 2032.
• The restricted stock units vest in three equal installments on the first, second, and third anniversaries of the grant date.
• The options also vest in three equal installments on the first, second, and third anniversary of the grant date.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options by the CFO could be seen as a slightly positive signal, but it's not definitively bullish.

Positives

• The acquisition of stock and options by the CFO could be interpreted as a positive sign of confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence from the CFO.

Key Dates

Keywords

Orthofix Medical Inc., OFIX, Form 4, Julie Andrews, CFO, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities